BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rizzo A, Nannini M, Astolfi A, Indio V, De Iaco P, Perrone AM, De Leo A, Incorvaia L, Di Scioscio V, Pantaleo MA. Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis. Cancers (Basel) 2020;12:E1899. [PMID: 32674439 DOI: 10.3390/cancers12071899] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zou Y, Xu Y, Chen X, Zheng L. Advances in the application of immune checkpoint inhibitors in gynecological tumors. International Immunopharmacology 2023;117:109774. [DOI: 10.1016/j.intimp.2023.109774] [Reference Citation Analysis]
2 Gent DG, Ali N, Olsson-Brown A, Lip GYH, Wright DJ, Dobson R. Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights. Case Rep Oncol 2022;15:950-9. [PMID: 36636681 DOI: 10.1159/000526256] [Reference Citation Analysis]
3 Suzuki T, Noguchi N, Shirane S, Ansai N, Sato T, Ise K, Murakami K, Murakami K, Nakamura Y, Ohta N. Cervical Liposarcoma Revisited: A Case Report and Scoping Literature Review. Case Rep Oncol 2022;15:881-6. [PMID: 36825093 DOI: 10.1159/000526862] [Reference Citation Analysis]
4 Galoian K, Dahl V, Perez A, Denny C, Becker B, Sedani A, Moran A, Martinez D, Hoyt A, Brown J. PRP-1, a toll-like receptor ligand, upregulates the unfolded protein response in human chondrosarcoma cells. Cancer Treat Res Commun 2022;33:100644. [PMID: 36368296 DOI: 10.1016/j.ctarc.2022.100644] [Reference Citation Analysis]
5 Abedin Y, Gabrilovich S, Alpert E, Rego E, Begum S, Zhao Q, Heller D, Einstein MH, Douglas NC. Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma. IJMS 2022;23:5980. [DOI: 10.3390/ijms23115980] [Reference Citation Analysis]
6 Badalamenti G, Incorvaia L, Algeri L, Bonasera A, Dimino A, Scalia R, Cucinella A, Madonia G, Pomi FL, Galvano A, Gristina V, Toia F, Cordova A, Bazan V, Russo A. Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement. Ther Adv Med Oncol 2022;14:175883592210868. [DOI: 10.1177/17588359221086829] [Reference Citation Analysis]
7 Chantharasamee J, Wong K, Potivongsajarn P, Qorbani A, Motamed N, Brackert S, Cohen J, Chmielowski B, Kalbasi A, Rao J, Nelson S, Singh A. Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma. Cancer Med 2022. [PMID: 35307963 DOI: 10.1002/cam4.4665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dall GV, Hamilton A, Ratnayake G, Scott C, Barker H. Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient Benefit. Cancers 2022;14:1561. [DOI: 10.3390/cancers14061561] [Reference Citation Analysis]
9 Hamed RA, Marks S, Mcelligott H, Kalachand R, Ibrahim H, Atyani S, Korpanty G, Osman N. Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre). Mol Clin Oncol 2022;16:40. [PMID: 35003738 DOI: 10.3892/mco.2021.2472] [Reference Citation Analysis]
10 Hadjimichael AC, Foukas AF, Papadimitriou E, Kaspiris A, Peristiani C, Chaniotakis I, Kotsari M, Pergaris A, Theocharis S, Sarantis P, Christopoulou M, Psyrri A, Mavrogenis AF, Savvidou OD, Papagelopoulos PJ, Armakolas A. Doxycycline inhibits the progression of metastases in early-stage osteosarcoma by downregulating the expression of MMPs, VEGF and ezrin at primary sites. Cancer Treatment and Research Communications 2022;32:100617. [DOI: 10.1016/j.ctarc.2022.100617] [Reference Citation Analysis]
11 Dondi G, Porcu E, De Palma A, Damiano G, De Crescenzo E, Cipriani L, Dirodi M, Ravegnini G, De Leo A, Nannini M, Ferioli M, Morganti AG, Pantaleo MA, De Iaco P, Perrone AM. Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review. Cancers (Basel) 2021;13:5808. [PMID: 34830960 DOI: 10.3390/cancers13225808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hanvic B, Ray-Coquard I. Gynecological sarcomas: literature review of 2020. Curr Opin Oncol 2021;33:345-50. [PMID: 34009140 DOI: 10.1097/CCO.0000000000000753] [Reference Citation Analysis]
13 Badalamenti G, Vincenzi B, Cani M, Incorvaia L. Soft Tissue Sarcomas (STS). Practical Medical Oncology Textbook 2021. [DOI: 10.1007/978-3-030-56051-5_58] [Reference Citation Analysis]